Article
Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer.
Molecular carcinogenesis - 1 Dec 2013
Liu Li, Wu Jing, Zhong Rong, Wu Chen, Zou Li, Yang Beifang, Chen Wei, Zhu Beibei, Duan Shengyu, Yu Dianke, Tan Wen, Nie Shaofa, Lin Dongxin, Miao Xiaoping
Abstract excerpt
Polymorphisms in DNA repair and apoptotic pathways may cause variations in chemosensitivity of non-small-cell lung cancer (NSCLC) through complex gene-gene and gene-environment interactions. A total of 200 advanced NSCLC patients who received platinum-based chemotherapies were recruited. The short-term clinical outcomes were classified as chemosensitive group, including complete remission (CR) and partial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
